Skip to main content
OpenTrials
Completed

NCT Number: NCT06903390

Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study

Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients.

The main questions this study aims to answer are:

What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels.

Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care.

A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety.

This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care.

This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Marmara Üniversitesi

Istanbul, Kadıköy, 34722, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients must be over 18 years old.
  • Must understand and speak Turkish.
  • Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders).
  • For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.

Exclusion criteria

  • Patients without regular outpatient follow-up visits.
  • Patients with severe cognitive or physiological deterioration affecting participation.
  • Patients who do not comply with the study process and requirements.
  • Patients who voluntarily request to withdraw from the study.

Treatment and study plan

QPL-based Communication Intervention

Behavioral

This QPL-based communication intervention stands out with the following key features:

Patient-Centered & Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety.

Structured Training & Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits.

Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation.

RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care.

Focus on Empowerment & Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS).

These features differentiate this intervention by offering a structured, culturally relevant approach.

Primary outcomes

  1. Change in Patient Empowerment Score

    Time frame: Immediately before the first consultation and within 1 day after the second and third consultations

    Assessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.

  2. Change in Anxiety Level (HADS)

    Time frame: Immediately before the first consultation and within 1 day after the second and third consultations

    Measured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.

Sponsors and collaborators

Lead sponsor

Marmara University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 30, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.